GlassScriptPhysician profile
Maria Morales
NPI 1295968824
$6,418.37
in general payments reported to CMS, 2019-2025
24 companies · $593 in 2025
The $593 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2021: $133 · 2022: $695 · 2023: $2,697 · 2024: $2,061 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,235 · Food and Beverage: $2,083 · Education: $1,000 · Gift: $33.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,234.54 |
| Food and Beverage | $2,083.22 |
| Education | $1,000.00 |
| Gift | $33.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,801.65 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $391.73 | 2019-2025 | |
| Exact Sciences Corporation | $170.23 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Baxter Healthcare | $133.53 | 2023-2025 | Perclot, Seprafilm, Floseal |
| Smith+Nephew, INC. | $132.27 | 2022 | |
| Astellas Pharma US INC | $115.36 | 2023-2025 | Veozah, Myrbetriq |
| Lsi Solutions INC | $97.79 | 2025 | Fornisee |
| Coopersurgical, INC. | $84.69 | 2022-2024 | Paragard T 380a |
| Channel Medsystems, INC. | $70.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $45.32 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.17 | 2021-2023 | |
| Dilon Technologies, INC. | $36.81 | 2024 | Hemoblast Bellows |
| Evofem Biosciences, INC. | $35.40 | 2021-2025 | Phexxi, Solosec, Phexx |
| Vertex Pharmaceuticals Incorporated | $34.38 | 2025 | |
| Scynexis, INC. | $33.62 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $32.35 | 2025 | |
| Heron Therapeutics, INC. | $26.23 | 2023 | Zynrelef |
| Novo Nordisk INC | $25.00 | 2025 | Rybelsus, Ozempic |
| Myovant Sciences INC. | $23.09 | 2022 | |
| Insulet Corporation | $21.15 | 2025 | Omnipod |
| Biogen, INC. | $19.60 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $19.23 | 2022 | |
| Sumitomo Pharma America, INC. | $16.92 | 2024 | Myfembree |
| Therapeuticsmd, INC. | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.